Procter & Gamble (NYSE:PG – Get Free Report) had its price objective decreased by equities research analysts at Piper Sandler from $173.00 to $172.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. Piper Sandler’s target price points to a potential upside of 1.08% from the stock’s current price.
A number of other equities analysts have also recently issued reports on the company. UBS Group reissued a “buy” rating on shares of Procter & Gamble in a report on Monday, February 10th. JPMorgan Chase & Co. dropped their target price on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. Royal Bank of Canada reissued a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a report on Thursday, January 23rd. Wells Fargo & Company increased their target price on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a report on Thursday, January 23rd. Finally, Barclays increased their target price on Procter & Gamble from $155.00 to $159.00 and gave the stock an “equal weight” rating in a report on Thursday, January 23rd. Eight analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average price target of $180.42.
Read Our Latest Research Report on PG
Procter & Gamble Trading Up 1.8 %
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.86 by $0.02. The firm had revenue of $21.88 billion during the quarter, compared to analysts’ expectations of $21.66 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The company’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.84 EPS. As a group, equities analysts forecast that Procter & Gamble will post 6.91 EPS for the current year.
Insider Buying and Selling at Procter & Gamble
In related news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction dated Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the transaction, the chief executive officer now owns 39,977 shares in the company, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Marc S. Pritchard sold 90,450 shares of the business’s stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $163.84, for a total value of $14,819,328.00. Following the sale, the insider now owns 172,814 shares of the company’s stock, valued at approximately $28,313,845.76. This represents a 34.36 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.18% of the company’s stock.
Institutional Investors Weigh In On Procter & Gamble
Institutional investors have recently made changes to their positions in the stock. Norges Bank acquired a new position in shares of Procter & Gamble during the fourth quarter worth $5,244,463,000. Raymond James Financial Inc. bought a new stake in shares of Procter & Gamble in the fourth quarter worth $1,010,685,000. Geode Capital Management LLC grew its stake in shares of Procter & Gamble by 7.0% in the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares during the last quarter. Bank Julius Baer & Co. Ltd Zurich boosted its position in Procter & Gamble by 1,195.1% during the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,222,585 shares of the company’s stock valued at $580,596,000 after acquiring an additional 2,973,757 shares during the last quarter. Finally, Capital Research Global Investors boosted its position in Procter & Gamble by 62.5% during the fourth quarter. Capital Research Global Investors now owns 7,398,120 shares of the company’s stock valued at $1,240,294,000 after acquiring an additional 2,846,560 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How to Find Undervalued Stocks
- Cadence: Long Term Outlook Still Strong Despite Double-Digit Drop
- Health Care Stocks Explained: Why You Might Want to Invest
- Beyond the Magnificent 7: Tech’s Rising Stars
- The Significance of Brokerage Rankings in Stock Selection
- Cisco: Tech Dividend Payer With Long Term AI Potential
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.